相似文献
1
Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.
J Clin Microbiol. 2005 Dec;43(12):6139-43. doi: 10.1128/JCM.43.12.6139-6143.2005.
2
Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.
J Bacteriol. 2005 May;187(9):2939-47. doi: 10.1128/JB.187.9.2939-2947.2005.
3
Biological and immunological characteristics of lipooligosaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis.
Infect Immun. 2007 Jun;75(6):2974-80. doi: 10.1128/IAI.01915-06. Epub 2007 Mar 19.
4
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
Infect Immun. 2005 May;73(5):2790-6. doi: 10.1128/IAI.73.5.2790-2796.2005.
5
Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
Arch Med Res. 2010 Oct;41(7):530-5. doi: 10.1016/j.arcmed.2010.10.003.
6
Improved pulsed field gel electrophoresis method for Moraxella catarrhalis.
J Microbiol Methods. 2008 Oct;75(2):344-5. doi: 10.1016/j.mimet.2008.05.021. Epub 2008 Jun 30.
7
Towards understanding the functional role of the glycosyltransferases involved in the biosynthesis of Moraxella catarrhalis lipooligosaccharide.
FEBS J. 2007 Apr;274(8):2024-37. doi: 10.1111/j.1742-4658.2007.05746.x. Epub 2007 Mar 27.
8
Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Clin Microbiol Infect. 2007 Oct;13(10):1023-5. doi: 10.1111/j.1469-0691.2007.01776.x. Epub 2007 Jul 3.
9
Molecular characterization of clinical isolates of Moraxella catarrhalis by randomly amplified polymorphic DNA fingerprinting.
J Mol Microbiol Biotechnol. 2014;24(4):270-8. doi: 10.1159/000367662. Epub 2014 Sep 26.
10
High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
Microb Drug Resist. 2015 Oct;21(5):507-11. doi: 10.1089/mdr.2014.0217. Epub 2015 Apr 29.
引用本文的文献
1
Understanding the population structure of using core genome multilocus sequence typing (cgMLST) and a life identification number (LIN) code classification system.
bioRxiv. 2025 May 4:2025.04.30.651387. doi: 10.1101/2025.04.30.651387.
2
The characterization of carried in the general population.
Microb Genom. 2022 May;8(5). doi: 10.1099/mgen.0.000820.
3
Interactions of Bacteriophages and Bacteria at the Airway Mucosa: New Insights Into the Pathophysiology of Asthma.
Front Allergy. 2021 Jan 26;1:617240. doi: 10.3389/falgy.2020.617240. eCollection 2020.
4
Co-carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary.
PLoS One. 2020 Feb 7;15(2):e0229021. doi: 10.1371/journal.pone.0229021. eCollection 2020.
5
Use of next generation sequence to investigate potential novel macrolide resistance mechanisms in a population of Moraxella catarrhalis isolates.
Sci Rep. 2016 Oct 24;6:35711. doi: 10.1038/srep35711.
6
Comparative Genomic Analyses of the Moraxella catarrhalis Serosensitive and Seroresistant Lineages Demonstrate Their Independent Evolution.
Genome Biol Evol. 2016 Apr 6;8(4):955-74. doi: 10.1093/gbe/evw039.
7
An Unusual Carbohydrate Conformation is Evident in Moraxella catarrhalis Oligosaccharides.
Molecules. 2015 Aug 5;20(8):14234-53. doi: 10.3390/molecules200814234.
8
Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly.
Glycobiology. 2013 Aug;23(8):1013-21. doi: 10.1093/glycob/cwt042. Epub 2013 May 29.
9
Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.
J Bacteriol. 2010 Jul;192(14):3574-83. doi: 10.1128/JB.00121-10. Epub 2010 May 7.
10
Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.
Infect Immun. 2009 Oct;77(10):4548-58. doi: 10.1128/IAI.00294-09. Epub 2009 Aug 3.
本文引用的文献
1
Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence.
Infect Immun. 2005 Jul;73(7):4222-30. doi: 10.1128/IAI.73.7.4222-4230.2005.
2
Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.
J Bacteriol. 2005 May;187(9):2939-47. doi: 10.1128/JB.187.9.2939-2947.2005.
3
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.
Am J Respir Crit Care Med. 2005 Jul 15;172(2):195-9. doi: 10.1164/rccm.200412-1747OC. Epub 2005 Apr 1.
4
Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.
Glycobiology. 2005 Apr;15(4):409-19. doi: 10.1093/glycob/cwi018. Epub 2004 Dec 1.
5
Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation.
Infect Immun. 2004 Nov;72(11):6262-70. doi: 10.1128/IAI.72.11.6262-6270.2004.
6
The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells.
Infect Immun. 2004 Apr;72(4):1906-13. doi: 10.1128/IAI.72.4.1906-1913.2004.
7
Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.
Infect Immun. 2003 Nov;71(11):6426-34. doi: 10.1128/IAI.71.11.6426-6434.2003.
8
The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells.
Infect Immun. 2003 Sep;71(9):4977-84. doi: 10.1128/IAI.71.9.4977-4984.2003.
9
The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin.
Infect Immun. 2003 Jun;71(6):3302-9. doi: 10.1128/IAI.71.6.3302-3309.2003.
10
Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera.
Infect Immun. 2003 Apr;71(4):1843-8. doi: 10.1128/IAI.71.4.1843-1848.2003.
Zotero 插件